Table 4 Population size, deaths, and unadjusted and adjusted mortality rate per 1000 person-years (PY), overall and by select characteristics
From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
| Â | Populationa | Deaths | Person Years (PY) | Unadjusted mortality rate per 1000PY (SE) | Adjustedb mortality rate per 1000PY (SE) |
|---|---|---|---|---|---|
Overall | 9997 | 830 | 49588.88 | 16.74 (0.58) | 23.59 (0.69) |
Sex | Â | Â | Â | Â | Â |
Female | 1831 | 184 | 9303.73 | 19.78 (1.46) | 27.09 (1.71) |
Male | 8166 | 646 | 40285.14 | 16.04 (0.63) | 22.79 (0.75) |
History of IDU | Â | Â | Â | Â | Â |
Yes | 2141 | 377 | 11082.71 | 34.02 (1.75) | 45.21 (2.02) |
No | 5702 | 257 | 28875.05 | 8.90 (0.56) | 12.81 (0.67) |
Aboriginal ancestry | Â | Â | Â | Â | Â |
Yes | 467 | 123 | 2398.97 | 51.27 (4.62) | 58.36 (4.93) |
No | 4275 | 255 | 24627.65 | 10.35 (0.65) | 14.74 (0.77) |
Baseline CD4 (cells/μL) |  |  |  |  |  |
<350 | 7689 | 740 | 41016.06 | 18.04 (0.66) | 25.55 (0.79) |
≥350 | 2308 | 90 | 8572.82 | 10.50 (1.12) | 14.23 (1.29) |
Year of ART initiation | Â | Â | Â | Â | Â |
2000–2003 | 2381 | 399 | 20389.75 | 19.57 (0.98) | 31.29 (1.24) |
2004–2007 | 3058 | 287 | 17928.23 | 16.01 (0.95) | 21.03 (1.08) |
2008–2012 | 4558 | 144 | 11270.90 | 12.78 (1.07) | 13.75 (1.11) |